Search

Author/Creator Estrada, V

2. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). (25th November 2021)

Authors:
Podzamczer, D; Micán, R; Tiraboschi, J; Portilla, J; Domingo, P; Llibre, J M; Ribera, E; Vivancos, M J; Morano, L; Masiá, M; Gómez, C; Fanjul, F; Payeras, A; Inciarte, A; Estrada, V; Rivero, A; Castro, Á; Bernal, E; Vinuesa, D; Knobel, H
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. Issue 6 (9th January 2013)

Authors:
Ribera, E; Larrousse, M; Curran, A; Negredo, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Ferrer, P; Alvarez, ML; Arterburn, S; Martínez, E
Journal:
HIV medicine
Issue:
Volume 14:Issue 6(2013:Jul.)
Page Start:
327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Relationship between plasma bilirubin level and oxidative stress markers in HIV‐infected patients on atazanavir‐ vs. efavirenz‐based antiretroviral therapy. Issue 9 (3rd March 2016)

Authors:
Estrada, V; Monge, S; Gómez‐Garre, MD; Sobrino, P; Masiá, M; Berenguer, J; Portilla, J; Viladés, C; Martínez, E; Blanco, JR
Other Names:
Moreno Santiago investigator.; del Amo Julia investigator.; Dalmau David investigator.; Navarro Maria Luisa investigator.; González Maria Isabel investigator.; Garcia Federico investigator.; Rubio Rafael investigator.; Iribarren Jose Antonio investigator.; Gutiérrez Félix investigator.; Vidal Fra...
Journal:
HIV medicine
Issue:
Volume 17:Issue 9(2016:Oct.)
Page Start:
653
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio. Issue 6 (11th December 2014)

Authors:
Martínez, E; Ribera, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Larrousse, M; Curran, A; Negredo, E; Arterburn, S; Ferrer, P; Álvarez, ML
Journal:
HIV medicine
Issue:
Volume 16:Issue 6(2015:Jul.)
Page Start:
370
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The CD4:CD8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery. Issue 1 (6th September 2013)

Authors:
Serrano‐Villar, S; Moreno, S; Fuentes‐Ferrer, M; Sánchez‐Marcos, C; Ávila, M; Sainz, T; de, NGP; Fernández‐Cruz, A; Estrada, V
Journal:
HIV medicine
Issue:
Volume 15:Issue 1(2014:Jan.)
Page Start:
40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy. Issue 1 (23rd October 2019)

Authors:
Carr, A; Grund, B; Schwartz, AV; Avihingsanon, A; Badal‐Faesen, S; Bernadino, JI; Estrada, V; La Rosa, A; Mallon, PWG; Pujari, S; White, D; Wyman Engen, N; Ensrud, K; Hoy, JF
Journal:
HIV medicine
Issue:
Volume 21:Issue 1(2020)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗